产碳青霉烯酶肺炎克雷伯菌血流感染患者的临床分析
发布时间：2018-07-24 11:43
【摘要】：目的对医院血培养产碳青霉烯酶肺炎克雷伯菌感染患者进行临床资料分析,对高危因素和治疗经验进行总结,给以后临床用药提供经验指导。方法回顾性分析医院2014年1月-2015年8月期间血培养产碳青霉烯酶肺炎克雷伯菌感染患者15例,对临床资料包括年龄、性别、原发病、入院时的APACHⅡ评分、是否有静脉导管、前期抗菌药物使用、是否激素使用,以及治疗经过等统计总结。结果 15例患者中,死亡7例,死亡率46.7%,治疗中替加环素+泰能效果较好,成功率为66.7%。结论对于广谱抗菌药物的使用、深静脉置管、呼吸机支持以及其他部位培养到产碳青霉烯酶肺炎克雷伯菌的患者容易发生血流感染,死亡率仍较高,治疗上替加环素+泰能效果较好。
[Abstract]:Objective to analyze the clinical data of patients infected with Klebsiella pneumoniae in hospital blood culture and summarize the high risk factors and treatment experience. Methods from January 2014 to August 2015, 15 patients with Klebsiella pneumoniae infection from blood culture were retrospectively analyzed. The clinical data included age, sex, primary disease, APACH 鈪，
本文编号：2141267
[Abstract]:Objective to analyze the clinical data of patients infected with Klebsiella pneumoniae in hospital blood culture and summarize the high risk factors and treatment experience. Methods from January 2014 to August 2015, 15 patients with Klebsiella pneumoniae infection from blood culture were retrospectively analyzed. The clinical data included age, sex, primary disease, APACH 鈪，
本文编号：2141267
本文链接：https://www.wllwen.com/yixuelunwen/chuanranbingxuelunwen/2141267.html
最近更新
教材专著
